Impel NeuroPharma Inc. (IMPL) Prices 5.33M Share IPO at $15/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
Impel NeuroPharma Announces Pricing of $80.0 Million Initial Public Offering
April 22, 2021 6:48 PM EDTSEATTLE, April 22, 2021 (GLOBE NEWSWIRE) -- Impel NeuroPharma, Inc. (Impel), a late-stage pharmaceutical company focused on utilizing its proprietary technology to develop and commercialize transformative therapies for patients suffering from diseases with high unmet medical needs, today announced the pricing of its initial public offering of 5,333,334 shares of its common stock at a price to the public of $15.00 per share. All of the shares are being offered by Impel. The shares are expected to begin trading on The Nasdaq Global Market on April 23, 2021 under the symbol IMPL. The gross proceeds from the offering, before deducting underwriting discounts and... More
